November 3, 2023 Arcutis Third Quarter 2023 Financial Results & Business Update October 19, 2023 ARQT October 2023 Corporate Overview September 19, 2023 Arcutis Biotherapeutics Provides Positive Atopic Dermatitis Program Updates Presentation August 8, 2023 Arcutis Second Quarter 2023 Financial Results & Business Update December 12, 2022 Arcutis BioTherapeutics Phase 3 Atopic Dermatitis Topline Data Presentation August 1, 2022 Arcutis ZORYVE FDA Approval Presentation June 14, 2022 Seborrheic Dermatitis Phase 3 STRATUM Topline Presentation March 28, 2022 Arcutis Investor Day Presentation February 1, 2021 DERMIS-1/DERMIS-2 Phase 3 Plaque Psoriasis Topline Data Review December 9, 2020 Arcutis 2020 Virtual Investor Day Current page 1 Page 2 Next page next › Last page last »
September 19, 2023 Arcutis Biotherapeutics Provides Positive Atopic Dermatitis Program Updates Presentation
